Counseling

Four tips for building the business case for genetic counseling programs

At the 2026 NSGC Annual Conference, “Hire Power: Unleashing Your Inner Business Case Superhero” equipped genetic counselors with the tools and community to advocate for new and expanded positions. Participants left with practical frameworks, real-world insights, and a clearer path to making the case for new positions.

Blog
Education

Key takeaways:

  • Start with a needs assessment that defines the problem before requesting a new genetic counselor role.
  • Engage physician champions and other stakeholders before presenting a formal proposal.
  • Combine patient stories with metrics that demonstrate clinical, operational, and financial impact.
  • Connect benefits for patients and families with institutional goals to strengthen the case for growth.

The case for expanding genetic counselor positions

Securing institutional support for new clinical positions is a challenge across healthcare. Whether the need is in neurology, oncology, or another specialty, clinicians and program leaders who can see a gap in patient care often find themselves without the training or tools to make a compelling case for it. Business case development is rarely part of graduate or clinical education, and that leaves many providers underprepared to advocate for expanded services, regardless of specialty.

Genetic counseling is a clear example. Demand for these services keeps growing, yet establishing or expanding genetic counselor positions remains difficult. That access gap has real consequences. For many families, the path to a genetic diagnosis can take years. Along the way, they move through rounds of testing while carrying questions no one has had time and sometimes the expertise to answer: What does this mean? What do we do now? Genetic counselors play a critical role in shortening that journey. They translate complex genomic information into something families can understand and act on, and help patients and care teams figure out what comes next. But access remains a challenge: demand is high, caseloads are full, and many clinics do not have the staffing to keep pace.

Additionally, the business impact of genetic counseling is often poorly understood. That makes it harder for healthcare leaders to weigh new or expanded roles against staffing, budgets, and organizational priorities. Recognizing this gap, the National Society of Genetic Counselors (NSGC) partnered with a variety of stakeholders to develop evidence-based business case toolkits for cancer and pediatric neurology. These toolkits offer practical frameworks, financial modeling templates, and compelling data to help genetic counselors tell the story of their value in the language decision makers speak.

Putting the NSGC business case toolkits to work

A toolkit works best when people know how to use it. At the 2026 NSGC Annual Conference, a workshop called “Hire Power: Unleashing Your Inner Business Case Superhero” brought genetic counselors together to do exactly that. This interactive session equipped participants with the tools and knowledge needed to successfully advocate for new genetic counselor positions. It introduced them to NSGC’s business case toolkits and showed how to apply them in their own settings.

Moderated by Sarah Soto, MS, CGC, Sr. Director, Payor Evidence & Coverage Strategy at GeneDx, the panel included Julie Cohen, ScM, CGC, Director of Genetic Counseling Services at Kennedy Krieger Institute and an Associate Professor of Neurology and Genetic Medicine at Johns Hopkins University School of Medicine; Kelly Johnson, RN, MS, Associate Regional Vice President for the Continental Division of HCA Healthcare Sarah Cannon Cancer Network; Charlie King, MGC, CGC, Clinical Science Liaison at Ambry Genetics; and Beth Rosen Sheidley, MS, CGC, Director of Genetic Counseling for the Department of Neurology at Boston Children’s Hospital. All brought a range of perspectives, including insights on the financial metrics, institutional priorities, and strategic considerations that shape executive-level hiring decisions.

Through guided exercises, participants began building their own customized business cases while trading experiences with peers facing similar challenges. Although the toolkits focus on two practice areas, the core concepts and exercises were designed to apply across any specialty or level of experience.

The session sent participants home with actionable strategies, practical resources, and renewed confidence to champion the value of genetic counseling. Here are four key learnings from the session:

Tip 1: Start with the problem, not the position

Every strong business case starts with a story: why does this position need to exist? Before advocating for a new genetic counselor role, document the unmet need. The toolkits recommend conducting a needs assessment that looks at factors such as wait times, referral volume, patient access challenges, staff workload, workflow inefficiencies, and organizational priorities. Administrators are often more responsive to a clearly defined problem than a request for additional headcount. Know the value proposition, meaning the specific patient need or gap, and lead with it.

Tip 2: Build champions before you build a proposal

One of the most consistent themes across both toolkits is the importance of buy-in. Genetic counselors are encouraged to identify physician champions and engage a variety of key stakeholders early, including clinicians, administrators, billing teams, patient advocates, and other decision-makers. Building relationships before making a formal ask creates momentum and support when it is time to present. As the session emphasized, the genetic counselor community is a resource too: peers facing similar challenges are valuable allies, not just colleagues.

Tip 3: Build your case with data and pair with stories leadership won’t forget

Leadership pays attention to numbers that connect to their own priorities. The toolkits recommend collecting metrics that show impact, such as wait times, appointment volume, staffing capacity, patient satisfaction, diagnostic yield, workflow efficiency, and revenue generation. Numbers alone rarely carry a proposal, though. Pair them with one or two patient stories that show what those figures mean for real families, so leaders see both the clinical and financial value of genetic counselor positions. Start with the metrics you can already pull, ask your finance or billing team for the ones you can’t, and use the toolkit templates to organize what you find. Then share a draft with colleagues in the GC community who have made similar proposals. Their examples and feedback can help you tighten the case before it reaches decision makers.

“Pair them with one or two patient stories that show what those figures mean for real families, so leaders see both the clinical and financial value of genetic counselor positions.”

~Sarah Soto, MS, CGC
Sarah Soto NSGC Quote

Tip 4: Connect patient impact to organizational value

Successful business cases go beyond explaining how genetic counselors support patients. The toolkits recommend demonstrating how genetic counseling contributes to institutional goals through improved quality metrics, increased efficiency, reduced delays in care, patient retention, market differentiation, downstream revenue, and support for research and precision medicine initiatives. Framing benefits in terms of both patient outcomes and organizational priorities, and being prepared to refine, realign, and resubmit if the first answer is “not yet,” is what ultimately moves a proposal forward.

Why this matters to families

Stronger advocacy for genetic counselor positions ultimately means improved patient access to essential care. Every new or expanded position means more patients and families who can sit down with someone who will help them make sense of a result, decide what to do next, and feel supported along the way. The need is undeniable: families are waiting.

The NSGC toolkits give genetic counselors practical strategies, proven frameworks, and real-world examples to move ideas into action. Whether seeking to establish a new genetics program, expand an existing team, or secure additional resources, the message from the 2026 NSGC Annual Conference was clear: The gap in access is real. So is the path to closing it.

Build your business case for genetic counselor positions

Explore NSGC’s cancer and pediatric neurology toolkits for resources to support your proposal.

‍

About the authors
Sarah Soto
,
MS CGC
Payor Coverage and Evidence Strategy

Sarah Soto, a board-certified, licensed genetic counselor, began her career as a clinical reproductive genetic counselor. Sarah then transitioned to a number of industry roles, including evaluating preauthorization genetic testing requests for medical necessity at Humana and writing and reviewing Health Technology Assessments—unbiased, evidence-based reviews of genetic tests and their clinical applications – at Hayes.

Most recently, Sarah worked at Myriad Genetics and now at GeneDx, where she focuses on strategy and clinical evidence from the payor perspective for both current and future products. Sarah has lectured at national and international conferences and various genetic counseling training programs on topics related to reproductive genetics or payer coverage and reimbursement.

View profile

Related articles

Insurance Coverage
Exome
Genome
Five questions every clinical note should answer to support genetic testing coverage

A strong clinical note helps insurance reviewers understand why exome or genome sequencing is medically necessary for your patient.

Explore five key questions insurance reviewers look to clinical documentation to answer—and how addressing them can help support insurance coverage and timely access to testing.

Financial
Genomics
Why year-end can be a good time to order genetic testing

As year-end approaches, some patients may have met more of their annual insurance deductible, potentially reducing out-of-pocket costs for covered genetic testing. Consider which patients may benefit from another conversation about exome or genome sequencing before benefits reset.

Developmental Delay
Epilepsy
Exome
Rare Disease Diagnostics
Mora’s story: How an early SYNGAP1 diagnosis changed her care

When Mora began missing developmental milestones, her parents trusted their instincts and continued searching for answers. Exome sequencing identified SYNGAP1-related disorder, helping her family and care team proactively monitor for seizures and access earlier interventions and specialized care.

Science that serves people

We’re scientists, but we’re also parents, siblings, and caregivers who understand how powerful an answer can be.